243 related articles for article (PubMed ID: 20658659)
1. 1,2,3-thiadiazole thioacetanilides. Part 2: Synthesis and biological evaluation of a new series of 2-{[4-(3,4-dichlorophenyl)-1,2,3-thiadiazol-5-yl]sulfanyl}acetanilides as HIV-1 inhibitors.
Zhan P; Liu XY; Li ZY; Fang ZJ; Pannecouque C; De Clercq E
Chem Biodivers; 2010 Jul; 7(7):1717-27. PubMed ID: 20658659
[TBL] [Abstract][Full Text] [Related]
2. 1,2,3-Thiadiazole thioacetanilides as a novel class of potent HIV-1 non-nucleoside reverse transcriptase inhibitors.
Zhan P; Liu X; Cao Y; Wang Y; Pannecouque C; De Clercq E
Bioorg Med Chem Lett; 2008 Oct; 18(20):5368-71. PubMed ID: 18824350
[TBL] [Abstract][Full Text] [Related]
3. 1,2,3-Selenadiazole thioacetanilides: synthesis and anti-HIV activity evaluation.
Zhan P; Liu X; Fang Z; Pannecouque C; De Clercq E
Bioorg Med Chem; 2009 Sep; 17(17):6374-9. PubMed ID: 19647440
[TBL] [Abstract][Full Text] [Related]
4. Novel 1,2,3-thiadiazole derivatives as HIV-1 NNRTIs with improved potency: Synthesis and preliminary SAR studies.
Zhan P; Liu X; Li Z; Fang Z; Li Z; Wang D; Pannecouque C; Clercq ED
Bioorg Med Chem; 2009 Aug; 17(16):5920-7. PubMed ID: 19620009
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of imidazole thioacetanilides as novel non-nucleoside HIV-1 reverse transcriptase inhibitors.
Zhan P; Liu X; Zhu J; Fang Z; Li Z; Pannecouque C; Clercq ED
Bioorg Med Chem; 2009 Aug; 17(16):5775-81. PubMed ID: 19643613
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and anti-HIV activity evaluation of 2-(4-(naphthalen-2-yl)-1,2,3-thiadiazol-5-ylthio)-N-acetamides as novel non-nucleoside HIV-1 reverse transcriptase inhibitors.
Zhan P; Liu X; Fang Z; Li Z; Pannecouque C; De Clercq E
Eur J Med Chem; 2009 Nov; 44(11):4648-53. PubMed ID: 19628308
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological activity of naphthyl-substituted (B-ring) benzophenone derivatives as novel non-nucleoside HIV-1 reverse transcriptase inhibitors.
Ma XD; Zhang X; Dai HF; Yang SQ; Yang LM; Gu SX; Zheng YT; He QQ; Chen FE
Bioorg Med Chem; 2011 Aug; 19(15):4601-7. PubMed ID: 21719299
[TBL] [Abstract][Full Text] [Related]
8. Arylazolylthioacetanilide. Part 11: design, synthesis and biological evaluation of 1,2,4-triazole thioacetanilide derivatives as novel non-nucleoside HIV-1 reverse transcriptase inhibitors.
Li Z; Cao Y; Zhan P; Pannecouque C; Balzarini J; Clercq ED; Shen Y; Liu X
Med Chem; 2013 Nov; 9(7):968-73. PubMed ID: 23072552
[TBL] [Abstract][Full Text] [Related]
9. Arylazolyl(azinyl)thioacetanilides. Part 10: design, synthesis and biological evaluation of novel substituted imidazopyridinylthioacetanilides as potent HIV-1 inhibitors.
Li X; Zhan P; Liu H; Li D; Wang L; Chen X; Liu H; Pannecouque C; Balzarini J; De Clercq E; Liu X
Bioorg Med Chem; 2012 Sep; 20(18):5527-36. PubMed ID: 22883027
[TBL] [Abstract][Full Text] [Related]
10. Arylazolylthioacetanilide. Part 8: Design, synthesis and biological evaluation of novel 2-(2-(2,4-dichlorophenyl)-2H-1,2,4-triazol-3-ylthio)-N-arylacetamides as potent HIV-1 inhibitors.
Zhan P; Chen X; Li X; Li D; Tian Y; Chen W; Pannecouque C; De Clercq E; Liu X
Eur J Med Chem; 2011 Oct; 46(10):5039-45. PubMed ID: 21872971
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and anti-HIV activity of 4-(naphthalen-1-yl)-1,2,5-thiadiazol-3-hydroxyl derivatives.
Rai D; Chen W; Zhan P; Liu H; Tian Y; Liang X; De Clercq E; Pannecouque C; Balzarini J; Liu X
Chem Biol Drug Des; 2014 Oct; 84(4):420-30. PubMed ID: 24674646
[TBL] [Abstract][Full Text] [Related]
12. Tetrazole thioacetanilides: potent non-nucleoside inhibitors of WT HIV reverse transcriptase and its K103N mutant.
Muraglia E; Kinzel OD; Laufer R; Miller MD; Moyer G; Munshi V; Orvieto F; Palumbi MC; Pescatore G; Rowley M; Williams PD; Summa V
Bioorg Med Chem Lett; 2006 May; 16(10):2748-52. PubMed ID: 16503141
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of piperidine-substituted triazine derivatives as HIV-1 non-nucleoside reverse transcriptase inhibitors.
Chen X; Zhan P; Pannecouque C; Balzarini J; De Clercq E; Liu X
Eur J Med Chem; 2012 May; 51():60-6. PubMed ID: 22405288
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of N-aryl pyrrolidinones as novel anti-HIV-1 agents. Part 1.
Wu B; Kuhen K; Ngoc Nguyen T; Ellis D; Anaclerio B; He X; Yang K; Karanewsky D; Yin H; Wolff K; Bieza K; Caldwell J; He Y
Bioorg Med Chem Lett; 2006 Jul; 16(13):3430-3. PubMed ID: 16632349
[TBL] [Abstract][Full Text] [Related]
15. Non-nucleoside reverse transcriptase inhibitors (Part 18): synthesis and anti-HIV activity of 4-allylamino or 4-azido substituted diaryltriazines.
Xiong YZ; Hu HR; Chen FE; Balzarini J; Pannecouque C; de Clercq E
Yao Xue Xue Bao; 2009 Feb; 44(2):145-9. PubMed ID: 19408683
[TBL] [Abstract][Full Text] [Related]
16. Arylazolyl(azinyl)thioacetanilides. Part 16: Structure-based bioisosterism design, synthesis and biological evaluation of novel pyrimidinylthioacetanilides as potent HIV-1 inhibitors.
Li X; Lu X; Chen W; Liu H; Zhan P; Pannecouque C; Balzarini J; De Clercq E; Liu X
Bioorg Med Chem; 2014 Oct; 22(19):5290-7. PubMed ID: 25150090
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and anti-HIV properties of novel 6-phenylselenenyl-5-propyluracils.
Miazga A; Felczak K; Siwecka MA; Lipniacki A; Piasek A; Kulikowski T
Acta Biochim Pol; 2007; 54(4):863-8. PubMed ID: 18066398
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of 4-(hydroxyimino)arylmethyl diarylpyrimidine analogues as potential non-nucleoside reverse transcriptase inhibitors against HIV.
Feng XQ; Zeng ZS; Liang YH; Chen FE; Pannecouque C; Balzarini J; De Clercq E
Bioorg Med Chem; 2010 Apr; 18(7):2370-4. PubMed ID: 20307984
[TBL] [Abstract][Full Text] [Related]
19. Non-nucleoside HIV-1 reverse-transcriptase inhibitors. Part 10. Synthesis and anti-HIV activity of 5-alkyl-6-(1-naphthylmethyl)pyrimidin-4(3H)-ones with a mono- or disubstituted 2-amino function as novel 'dihydro-alkoxy-benzyl-oxopyrimidine' (DABO) analogues.
Wang Y; Chen FE; Balzarini J; De Clercq E; Pannecouque C
Chem Biodivers; 2008 Jan; 5(1):168-76. PubMed ID: 18205120
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and biological evaluation of cycloalkyl arylpyrimidines (CAPYs) as HIV-1 NNRTIs.
Gu SX; Yang SQ; He QQ; Ma XD; Chen FE; Dai HF; Clercq ED; Balzarini J; Pannecouque C
Bioorg Med Chem; 2011 Dec; 19(23):7093-9. PubMed ID: 22037050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
